Skip to main content
. 2011 Mar;18(3):269–276. doi: 10.1177/1933719110385709

Figure 3.

Figure 3.

BrdU uptake assay of granulosa cells by immune-fluorescence analysis. Granulosa cells synchronized at G1/S interphase were treated with 50 μmol/L SP600125 and AS601245 and BrdU uptake was compared between control and JNK inhibitor groups; 17% and 21 % of cells treated with 50 μmol/L SP600125 and AS601245, respectively, were BrdU positive compared to 55% of control cells (P < .001). JNK indicates c-Jun N-terminal kinase.